Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID 36C24120N0193· VHA· 241-NETWORK CONTRACT OFFICE 01 (36C241)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $119,315 net obligations· UEI KK5FBFA43JS7· MD

Description

TYVASO REFILLS- DEOBLIGATION

Base award description: TYVASO REFILLS

First action · last action
2019-12-19 · 2022-03-04
Transactions
3
First transaction's obligation
$540,922
Base + all options value (sum of deltas)
$660,237
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0007
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$555,952$0Base award · 2019-12-19 · this action $540,922 · running total $540,922Modification P00001 · 2020-01-23 · this action $15,030 · running total $555,952Modification P00002 · 2022-03-04 · this action -$436,636 · running total $119,315
  • Base2019-12-19+$540,922= $540,922
  • Mod P000012020-01-23+$15,030= $555,952
  • Mod P000022022-03-04-$436,636= $119,315
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-12-19+$540,922$540,922TYVASO REFILLS
Mod P00001· FUNDING ONLY ACTION2020-01-23+$15,030$555,952TYVASO REFILLS
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-03-04−$436,636$119,315TYVASO REFILLS- DEOBLIGATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24126P0328CARDINAL HEALTH 414, LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$999,797FY2026
36C24126F0121MCKESSON CORPORATION241-NETWORK CONTRACT OFFICE 01 (36C241)$16,333FY2026
36C24126F0112VANTIVE US HEALTHCARE LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$545,567FY2026
36C24126N0603AMERICAN NATIONAL RED CROSS, THE241-NETWORK CONTRACT OFFICE 01 (36C241)$1,998,719FY2026
36C24126F0109BOSTON SCIENTIFIC CORP241-NETWORK CONTRACT OFFICE 01 (36C241)$304,950FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24120N0193_3600_VA797P15A0007_3600 · retrieved 2026-09-26.